BIAF
Price
$0.27
Change
-$0.02 (-6.90%)
Updated
Jul 3 closing price
Capitalization
23.27M
44 days until earnings call
GGNDF
Price
$14.38
Change
+$1.38 (+10.62%)
Updated
Jun 5 closing price
Capitalization
3.89B
Interact to see
Advertisement

BIAF vs GGNDF

Header iconBIAF vs GGNDF Comparison
Open Charts BIAF vs GGNDFBanner chart's image
bioAffinity Technologies
Price$0.27
Change-$0.02 (-6.90%)
Volume$667.86K
Capitalization23.27M
GN Store Nord A/S
Price$14.38
Change+$1.38 (+10.62%)
Volume$228
Capitalization3.89B
BIAF vs GGNDF Comparison Chart in %
Loading...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GGNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIAF vs. GGNDF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAF is a Hold and GGNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BIAF: $0.27 vs. GGNDF: $14.38)
Brand notoriety: BIAF and GGNDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIAF: 7% vs. GGNDF: 30%
Market capitalization -- BIAF: $23.27M vs. GGNDF: $3.89B
BIAF [@Medical Specialties] is valued at $23.27M. GGNDF’s [@Medical Specialties] market capitalization is $3.89B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIAF’s FA Score shows that 0 FA rating(s) are green whileGGNDF’s FA Score has 1 green FA rating(s).

  • BIAF’s FA Score: 0 green, 5 red.
  • GGNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, GGNDF is a better buy in the long-term than BIAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIAF’s TA Score shows that 4 TA indicator(s) are bullish while GGNDF’s TA Score has 5 bullish TA indicator(s).

  • BIAF’s TA Score: 4 bullish, 4 bearish.
  • GGNDF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, GGNDF is a better buy in the short-term than BIAF.

Price Growth

BIAF (@Medical Specialties) experienced а -24.31% price change this week, while GGNDF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

BIAF is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GGNDF($3.89B) has a higher market cap than BIAF($23.3M). GGNDF YTD gains are higher at: -15.739 vs. BIAF (-70.066). GGNDF has higher annual earnings (EBITDA): 2.6B vs. BIAF (-7.01M). GGNDF has more cash in the bank: 676M vs. BIAF (4.51M). BIAF has less debt than GGNDF: BIAF (1.69M) vs GGNDF (16.7B). GGNDF has higher revenues than BIAF: GGNDF (19B) vs BIAF (321K).
BIAFGGNDFBIAF / GGNDF
Capitalization23.3M3.89B1%
EBITDA-7.01M2.6B-0%
Gain YTD-70.066-15.739445%
P/E RatioN/A32.89-
Revenue321K19B0%
Total Cash4.51M676M1%
Total Debt1.69M16.7B0%
FUNDAMENTALS RATINGS
GGNDF: Fundamental Ratings
GGNDF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIAFGGNDF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
34%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
29%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
30%
Advances
ODDS (%)
Bullish Trend 27 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
34%
View a ticker or compare two or three
Interact to see
Advertisement
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GGNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPOW0.950.04
+4.46%
Sunrise New Energy Co Ltd
SMLR40.450.91
+2.30%
Semler Scientific
BY28.380.40
+1.43%
Byline Bancorp
LOPE183.430.92
+0.50%
Grand Canyon Education
TAK15.34-0.08
-0.52%
Takeda Pharmaceutical Company Limited

BIAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIAF has been loosely correlated with RSLS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BIAF jumps, then RSLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-6.07%
RSLS - BIAF
45%
Loosely correlated
-2.07%
SNWV - BIAF
32%
Poorly correlated
-0.22%
HSCS - BIAF
29%
Poorly correlated
-5.56%
RDNT - BIAF
26%
Poorly correlated
N/A
TCMD - BIAF
24%
Poorly correlated
N/A
More

GGNDF and

Correlation & Price change

A.I.dvisor tells us that GGNDF and BIAF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GGNDF and BIAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GGNDF
1D Price
Change %
GGNDF100%
N/A
BIAF - GGNDF
20%
Poorly correlated
-6.07%
IRME - GGNDF
7%
Poorly correlated
N/A
GNNDY - GGNDF
5%
Poorly correlated
N/A
HOCPF - GGNDF
1%
Poorly correlated
+3.88%
FZMD - GGNDF
-0%
Poorly correlated
N/A
More